share_log

EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Altitude Life Science Ventures II, LLC(4.4%),David Maki(4.4%), etc.

EFFECTOR THERAPEUTICS INC C/WTS 31/12/2025 (TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-Altitude Life Science Ventures II, LLC(4.4%),David Maki(4.4%)等

美股sec公告 ·  02/05 16:20
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息